Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22


Changes and tracking of bone mineral density in late adolescence: the Tromsø Study, Fit Futures.

Nilsen OA, Ahmed LA, Winther A, Christoffersen T, Furberg AS, Grimnes G, Dennison E, Emaus N.

Arch Osteoporos. 2017 Dec;12(1):37. doi: 10.1007/s11657-017-0328-1. Epub 2017 Apr 8.


Debunking the curse of the rainbow jersey: historical cohort study.

Perneger T.

BMJ. 2015 Dec 14;351:h6304. doi: 10.1136/bmj.h6304.


The need to control for regression to the mean in social psychology studies.

Yu R, Chen L.

Front Psychol. 2015 Jan 8;5:1574. doi: 10.3389/fpsyg.2014.01574. eCollection 2014.


Strength and function response to clinical interventions of older women categorized by weakness and low lean mass using classifications from the Foundation for the National Institute of Health sarcopenia project.

Fragala MS, Dam TT, Barber V, Judge JO, Studenski SA, Cawthon PM, McLean RR, Harris TB, Ferrucci L, Guralnik JM, Kiel DP, Kritchevsky SB, Shardell MD, Vassileva MT, Kenny AM.

J Gerontol A Biol Sci Med Sci. 2015 Feb;70(2):202-9. doi: 10.1093/gerona/glu110. Epub 2014 Aug 18.


Associations between the 2007 Medicare reimbursement reduction for bone mineral density testing and osteoporosis drug therapy patterns of female Medicare beneficiaries.

Kim SJ, Lee JH, Kim S, Nakagawa S, Bertelson H, Lam J, Yoo JW.

Patient Prefer Adherence. 2014 Jun 25;8:909-15. doi: 10.2147/PPA.S62780. eCollection 2014.


Assessing regression to the mean effects in health care initiatives.

Linden A.

BMC Med Res Methodol. 2013 Sep 28;13:119. doi: 10.1186/1471-2288-13-119.


Nitrates and bone turnover (NABT) - trial to select the best nitrate preparation: study protocol for a randomized controlled trial.

Bucur RC, Reid LS, Hamilton CJ, Cummings SR, Jamal SA.

Trials. 2013 Sep 8;14:284. doi: 10.1186/1745-6215-14-284.


Ca/P concentration ratio at different sites of normal and osteoporotic rabbit bones evaluated by Auger and energy dispersive X-ray spectroscopy.

Kourkoumelis N, Balatsoukas I, Tzaphlidou M.

J Biol Phys. 2012 Mar;38(2):279-91. doi: 10.1007/s10867-011-9247-3. Epub 2011 Dec 14.


Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.


Clinical trials: discerning hype from substance.

Fleming TR.

Ann Intern Med. 2010 Sep 21;153(6):400-6. doi: 10.7326/0003-4819-153-6-201009210-00008. Erratum in: Ann Intern Med. 2011 Jul 19;155(2):136.


Tracking of bone mass and density during childhood and adolescence.

Kalkwarf HJ, Gilsanz V, Lappe JM, Oberfield S, Shepherd JA, Hangartner TN, Huang X, Frederick MM, Winer KK, Zemel BS.

J Clin Endocrinol Metab. 2010 Apr;95(4):1690-8. doi: 10.1210/jc.2009-2319. Epub 2010 Mar 1.


Bisphosphonate therapy: when not to monitor BMD.

Sharma U, Stevermer JJ.

J Fam Pract. 2009 Nov;58(11):594-6. No abstract available.


Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data.

Bell KJ, Hayen A, Macaskill P, Irwig L, Craig JC, Ensrud K, Bauer DC.

BMJ. 2009 Jun 23;338:b2266. doi: 10.1136/bmj.b2266.


Prediction of changes in bone mineral density in postmenopausal women treated with once-weekly bisphosphonates.

Burnett-Bowie SM, Saag K, Sebba A, de Papp AE, Chen E, Rosenberg E, Greenspan SL.

J Clin Endocrinol Metab. 2009 Apr;94(4):1097-103. doi: 10.1210/jc.2008-1122. Epub 2009 Jan 13.


Clinical challenges in the management of osteoporosis.

Vondracek SF, Minne P, McDermott MT.

Clin Interv Aging. 2008;3(2):315-29. Review.


Use of randomised trials to decide when to monitor response to new treatment.

Bell KJ, Irwig L, Craig JC, Macaskill P.

BMJ. 2008 Feb 16;336(7640):361-5. doi: 10.1136/bmj.39476.623611.25. No abstract available.


Osteoporosis in the aging male: treatment options.

Tuck SP, Datta HK.

Clin Interv Aging. 2007;2(4):521-36. Review.


Supplemental Content

Support Center